|
|
The European Charcot Foundation is a partner in Multiple Sclerosis research for Pharmaceutical Companies.
The European Charcot Foundation organized the following multicenter treatment trials:
-
Early Treatment of Multiple Sclerosis (ETOMS)
Sponsor: Ares-Serono.
-
European Study on IVIG Treatment in MS (ESIMS)
Sponsor: Bayer Vital.
-
Gammaglobulins in the Post Partum Period in MS for Prevention of Exacerbations after Delivery (GAMPP)
Sponsor: Octapharma.
-
Interferon beta 1A phase III trial (ORIGIMS)
Sponsor: BioPartners.
-
Counting Relapses After GAMPP Trial (CRAFT)
|
Print this page Tell-a-friend
|
